C
TMCI icon

Covestor’s Treace Medical Concepts TMCI Stock Holding History

Covestor’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34
Closed – – 2841
2026
Q1 		$0 Buy
34
+24
+240% +$48 ﹤0.01% 2767
2025
Q4 		$0 Hold
10
– – ﹤0.01% 2737
2025
Q3 		$0 Hold
10
– – ﹤0.01% 2772
2025
Q2 		$0 Sell
10
-1
-9% -$7 ﹤0.01% 2754
2025
Q1 		$0 Sell
11
-6
-35% -$54 ﹤0.01% 2728
2024
Q4 		$0 Buy
17
+10
+143% +$67 ﹤0.01% 2740
2024
Q3 		$0 Sell
7
-1
-13% -$6 ﹤0.01% 2767
2024
Q2 		$0 Hold
8
– – ﹤0.01% 2757
2024
Q1 		$0 Sell
8
-1
-11% -$13 ﹤0.01% 2738
2023
Q4 		$0 Buy
9
+4
+80% +$40 ﹤0.01% 2713
2023
Q3 		$0 Sell
5
-1
-17% -$18 ﹤0.01% 2711
2023
Q2 		$0 Hold
6
– – ﹤0.01% 2651
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2588
2022
Q4 		$0 Sell
6
-4
-40% -$92 ﹤0.01% 2611
2022
Q3 		$0 Sell
10
-1
-9% -$19 ﹤0.01% 2605
2022
Q2 		$0 Buy
+11
New +$185 ﹤0.01% 2368
2022
Q1 		– Sell
-18
Closed – – 2445
2021
Q4 		$0 Buy
+18
New +$371 ﹤0.01% 2302

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Covestor's TMCI Position: Q2 2026 in Review

Covestor sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 34 shares.

Covestor first reported a position in TMCI in Q4 2021 and held it in 17 quarters. The position peaked at $0 in Q1 2026. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Covestor reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Covestor sold 34 Treace Medical Concepts shares in Q2 2026.
  • Covestor first reported a position in Treace Medical Concepts in Q4 2021 and held it in 17 quarters.
  • Covestor's Treace Medical Concepts position peaked at $0 in Q1 2026.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.